Intrance Medical Systems
Intrance Medical Systems Inc., a subsidiary of Sweden-based Intrance Holdings AB, is a private biopharmaceutical company focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson’s disease in the U.S., Canada, Mexico, South America, Japan and Taiwan.
Intrance Medical Systems has raised €6.8M across 1 funding round from 1 investor, most recently a round in Sep 2021. Based in Stockholm, Sweden; active in Healthtech. Data as of 7 Aug 2026.
